NCT05743972View on ClinicalTrials.gov

Contrast-Enhanced Ultrasound vs Conventional US-guided Percutaneous Needle Biopsy for Pancreatic Diseases: Prospective Multicenter Randomized Controlled Trial

NANot yet recruitingINTERVENTIONAL
Enrollment

196

Participants

Timeline

Start Date

March 1, 2023

Primary Completion Date

December 1, 2025

Study Completion Date

February 1, 2026

Conditions
Pancreatic Disease
Interventions
DIAGNOSTIC_TEST

Contrast-enhanced ultrasound-guided core biopsy

Core biopsy was used to collect samples for pancreatic diseases under contrast-enhanced ultrasound-guided.

DIAGNOSTIC_TEST

Conventional ultrasound-guided core biopsy

Core biopsy was used to collect samples for pancreatic diseases under conventional ultrasound-guided.

Trial Locations (1)

350000

Fujian Provincial Hospital, Fuzhou

All Listed Sponsors
lead

xiao-yan xie

OTHER

NCT05743972 - Contrast-Enhanced Ultrasound vs Conventional US-guided Percutaneous Needle Biopsy for Pancreatic Diseases: Prospective Multicenter Randomized Controlled Trial | Biotech Hunter | Biotech Hunter